Esperion Therapeutics Inc. [ESPR] Records 50-Day SMA of $2.37
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Esperion Therapeutics Inc. shares valued at $924 were sold by Warren Eric on Sep 20 ’23. At $1.25 per share, Warren Eric sold 742 shares. The insider’s holdings dropped to 68,318 shares worth approximately […]
BofA Securities Downgrades Esperion Therapeutics Inc. (ESPR) to a Neutral from a Buy
Esperion Therapeutics Inc.’s filing revealed that its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $924.0 on Sep 20 ’23. In the deal valued at $1.25 per share,742 shares were sold. As a result of this transaction, Warren Eric now holds 68,318 shares worth roughly $0.14 million. Then, Warren Eric sold 243 shares, […]
Esperion Therapeutics Inc. [ESPR] Shares Fall Approximately -53.52% Over the Year
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Esperion Therapeutics Inc. shares valued at $924 were sold by Warren Eric on Sep 20 ’23. At $1.25 per share, Warren Eric sold 742 shares. The insider’s holdings dropped to 68,318 […]
Recent Insider Activity Suggests Potential Gains for Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc.’s recently made public that its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $924.0 on Sep 20. In the deal valued at $1.25 per share,742 shares were sold. As a result of this transaction, Warren Eric now holds 68,318 shares worth roughly $0.2 million. Then, Warren Eric sold 243 shares, […]
ESPR’s short interest reaches 20.07 million shares on Jan 31, 2024
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Esperion Therapeutics Inc. shares valued at $924 were sold by Warren Eric on Sep 20. At $1.25 per share, Warren Eric sold 742 shares. The insider’s holdings dropped to 68,318 shares worth approximately $0.18 […]
Understanding the Risks of Investing in Esperion Therapeutics Inc. (ESPR)
Esperion Therapeutics Inc.’s recently made public that its Chief Commercial Officer Warren Eric unloaded Company’s shares for reported $924.0 on Sep 20. In the deal valued at $1.25 per share,742 shares were sold. As a result of this transaction, Warren Eric now holds 68,318 shares worth roughly $0.17 million. Then, Warren Eric sold 243 shares, […]